Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Daver

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
International Journal of Oncology|May 3, 2011
Evaluation of the automated fluorescent analysis of the H-ras minisatellite after optimized PCR amplification in comparison with a standardized Southern blot techniqueS Gosse, S Sauvaigo, A Daver, et al.
European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
Quantitative determination of c-erbB-2 in human breast tumours: potential prognostic significance of low valuesS Koscielny, P Terrier, A Daver, et al.
Oncology Reports|February 15, 2000
Allelic imbalance at NBS1 is frequent in both proximal and distal colorectal carcinomaN Uhrhammer, J O Bay, S Gosse-Brun, et al.
Cytometry|May 1, 1984
Comparative flow DNA analysis of different cell suspensions in breast carcinomaA Chassevent, A Daver, G Bertrand, et al.
Anticancer Research|August 15, 1998
Association between H-ras minisatellite and colorectal cancer riskS Gosse-Brun, S Sauvaigo, A Daver, et al.
Clinical Chemistry|October 3, 1999
Kinetics of serum tumor marker concentrations and usefulness in clinical monitoringJ M Bidart, F Thuillier, C Augereau, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
Plasma sialic acid as a marker of the effect of the treatment on metastatic colorectal cancerT Painbeni, E Gamelin, A Cailleux, et al.
British Journal of Cancer|July 17, 1999
Prognostic value of uPA and p53 accumulation measured by quantitative biochemical assays in 1245 primary breast cancer patients: a multicentre studyP Broët, F Spyratos, S Romain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001
Thymidine kinase as a proliferative marker: clinical relevance in 1,692 primary breast cancer patientsP Broët, S Romain, A Daver, et al.
Oncology Reports|April 16, 1999
Loss of heterozygosity at the ATM locus in colorectal carcinomaN Uhrhammer, J Bay, D Pernin, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
International Journal of Oncology|May 3, 2011
Evaluation of the automated fluorescent analysis of the H-ras minisatellite after optimized PCR amplification in comparison with a standardized Southern blot techniqueS Gosse, S Sauvaigo, A Daver, et al.
European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
Quantitative determination of c-erbB-2 in human breast tumours: potential prognostic significance of low valuesS Koscielny, P Terrier, A Daver, et al.
Oncology Reports|February 15, 2000
Allelic imbalance at NBS1 is frequent in both proximal and distal colorectal carcinomaN Uhrhammer, J O Bay, S Gosse-Brun, et al.
Cytometry|May 1, 1984
Comparative flow DNA analysis of different cell suspensions in breast carcinomaA Chassevent, A Daver, G Bertrand, et al.
Anticancer Research|August 15, 1998
Association between H-ras minisatellite and colorectal cancer riskS Gosse-Brun, S Sauvaigo, A Daver, et al.
Clinical Chemistry|October 3, 1999
Kinetics of serum tumor marker concentrations and usefulness in clinical monitoringJ M Bidart, F Thuillier, C Augereau, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
Plasma sialic acid as a marker of the effect of the treatment on metastatic colorectal cancerT Painbeni, E Gamelin, A Cailleux, et al.
British Journal of Cancer|July 17, 1999
Prognostic value of uPA and p53 accumulation measured by quantitative biochemical assays in 1245 primary breast cancer patients: a multicentre studyP Broët, F Spyratos, S Romain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001
Thymidine kinase as a proliferative marker: clinical relevance in 1,692 primary breast cancer patientsP Broët, S Romain, A Daver, et al.
Oncology Reports|April 16, 1999
Loss of heterozygosity at the ATM locus in colorectal carcinomaN Uhrhammer, J Bay, D Pernin, et al.
Pageof 6